Adolescent Cannabis Use Linked to Psychiatric Risks
Analysis based on 10 articles · First reported Feb 20, 2026 · Last updated Feb 25, 2026
The study's findings could negatively impact the Cannabis industry due to increased public health concerns and potential regulatory pressures. It may also boost demand for mental health services and pharmaceutical solutions for psychiatric disorders.
A new longitudinal study published in List of American Medical Association journals, co-authored by researchers from Kaiser Permanente, the Public Health Institute, the University of California, San Francisco, and the University of Southern California, and funded by the United States===National Institute on Drug Abuse, found a significant link between adolescent Cannabis use and a doubled risk of developing psychotic and bipolar disorders, as well as heightened risks of depression and anxiety. The study, which followed over 463,000 individuals from ages 13 to 26, analyzed electronic health record data from 2016 to 2023. It highlighted that psychiatric diagnoses typically occurred 1.7 to 2.3 years after reported Cannabis use. The research also noted that higher THC potency in modern Cannabis products and increased use among adolescents in socioeconomically deprived neighborhoods, including those on United States===Medicaid, are exacerbating mental health disparities. Lynn L. Silver and Kelly Young-Wolff emphasized the urgent need for public health responses to reduce Cannabis potency, limit youth exposure, and prioritize prevention.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard